Advertisement
News
Subscribe to MDT Magazine News

OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment

May 24, 2011 5:34 am | by Bio-Medicine.Org | Comments

MADISON, N.J. and AUSTIN, Texas, May 24, 2011 /- A paper published in the June issue of Obstetrics & Gynecology demonstrated that adding OVA1 to a physician's preoperative assessment of a woman's ovarian mass would identify more ovarian cancers than a physician's preoperative...

TOPICS:

AmbiCom Renews and Expands Line of Credit With East West Bank

May 24, 2011 5:34 am | by Bio-Medicine.Org | Comments

MILPITAS, Calif., May 24, 2011 /- AmbiCom Holdings, Inc. (OTCQB: ABHI), a leader in the development of wireless products for medical equipment suppliers, today announced that it has signed a new line of credit with East West Bank, renewing and expanding the credit line that was due to...

TOPICS:

KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP201 for Pain

May 24, 2011 5:34 am | by Bio-Medicine.Org | Comments

NORTH LIBERTY, Iowa, May 24, 2011 /- KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of its most advanced opioid-based drug candidate, KP201, a novel hydrocodone prodrug for treating pain.  KP201 is a new chemical entity (NCE) composed of hydrocodone...

TOPICS:
Advertisement

ResMed Announces New iPhone App

May 24, 2011 5:33 am | by Bio-Medicine.Org | Comments

SAN DIEGO, May 24, 2011 /- ResMed (NYSE: RMD ) today released the ResMed Sleep Assessment app, a novel new app for iPhone that lets users record themselves during sleep. The app also includes a clinically validated questionnaire that assesses their risk and other helpful features to...

TOPICS:

Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment

May 24, 2011 5:33 am | by Bio-Medicine.Org | Comments

PALO ALTO, Calif. and AUCKLAND, New Zealand, May 24, 2011 /- Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc. (NYSE: VAR ), and Auckland UniServices Ltd. of Auckland, New Zealand, today announced that they have entered into a licensing agreement granting Centella...

TOPICS:

Medtronic 4Q profit drops on job-cutting expenses

May 24, 2011 3:45 am | by The Associated Press | Comments

Medtronic, the world's largest medical device maker, says its fourth-quarter net income dropped 19 percent on expenses related to its recent layoffs.The Minneapolis-based company earned $776 million, or 72 cents per share, down from $954 million, or 86 cents per share, a year ago. Excluding...

Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

May 24, 2011 3:34 am | by Bio-Medicine.Org | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017...

TOPICS:

Reportlinker Adds United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017

May 24, 2011 3:33 am | by Bio-Medicine.Org | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017...

TOPICS:
Advertisement

Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis

May 24, 2011 2:33 am | by Bio-Medicine.Org | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis...

TOPICS:

Boston Heart Lab Changes Name to Boston Heart Diagnostics

May 24, 2011 2:32 am | by Bio-Medicine.Org | Comments

FRAMINGHAM, Mass., May 24, 2011 /- Framingham-based Boston Heart Lab announced that it is changing its name to Boston Heart Diagnostics. The company launched its new name and logo at the National Lipid Association Scientific Sessions conference, held May 19-22 in New York City. (Logo:...

TOPICS:

Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides

May 24, 2011 1:34 am | by Bio-Medicine.Org | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Leukemia, Lymphoma and Peptides...

TOPICS:

Prometheus Announces Agreement to be Acquired by Nestle Health Science

May 23, 2011 11:32 pm | by Bio-Medicine.Org | Comments

SAN DIEGO, May 24, 2011 /- Prometheus Laboratories Inc., ("Prometheus") a specialty pharmaceutical and diagnostic company, today announced that it has entered into a definitive agreement to be acquired by Nestle Health Science S.A., a wholly-owned subsidiary of Nestle S.A., for an...

TOPICS:

EndyMed Announces the World's First 3DEEP RF Skin Tightening and Fractional Skin Resurfacing Combined Treatment Platform

May 23, 2011 12:35 pm | by Bio-Medicine.Org | Comments

CAESAREA, Israel, May 23, 2011 /- EndyMed Medical, Ltd., www.endymed.com , a leader in the use of multi-source radiofrequency for professional aesthetic treatments, announced today that the results of a new study will be presented at the upcoming 22nd World Congress of Dermatology, in...

TOPICS:

VTI?s 3D MEMS technology: small size, high quality and low power sensors for healthcare devices

May 23, 2011 11:36 am | by I-Micronews | Comments

Healthcare applications account for approximately 15% of the total value of the MEMS (Micro Electro Mechanical Systems) market, and it is expected that the figure will rise to 25% by the year 2015.

Analog devices' IMEMS dual-axis accelerometer delivers guaranteed high temperature operation up to +175° c

May 23, 2011 11:35 am | by I-Micronews | Comments

ADI?s ADXL206 iMEMS® accelerometer measures acceleration with a full-scale range of ±5 g with 1 mg resolution and a temperature range of -40° C to +175° C.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading